Sales & Marketing News | pharmaphorum

News

Changing Faces: agency, consultant, and investor hires from ...

Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors.

News

Mirati challenges Amgen with FDA okay for KRAS drug

Amgen has its first direct competition in the KRAS inhibitor class following FDA approval of Mirati's adagrasib as Krazati for a form of lung cancer.

News

GSK to move HQ to central London, as Canary Wharf plans file...

This week saw two major life sciences investments in London, as GSK unveiled plans to move its headquarters to a central location in the city, while an ambitious plan to develop a new biosc

News

Roche's head of pharma Bill Anderson heads for exit

Roche announced this morning that its head of pharmaceuticals, Bill Anderson, is leaving the company to pursue "other opportunities" after four years in the role.

News

Amgen agrees $26bn for Horizon following Sanofi withdrawal

In a fresh update, Bloomberg has reported that US biotech Amg

Views & Analysis

An inside peek into pharma marketing at PM Society learning ...

The PM Society’s ‘Is Pharma Marketing built on Straw, Sticks, or Bricks?’ interactive information afternoon, held at The Royal Society of Medicine in London on Tuesday 6th December, set out

Changing Faces: agency, consultant, and investor hires from ...

Mirati challenges Amgen with FDA okay for KRAS drug

GSK to move HQ to central London, as Canary Wharf plans file...

Roche's head of pharma Bill Anderson heads for exit

Amgen agrees $26bn for Horizon following Sanofi withdrawal

An inside peek into pharma marketing at PM Society learning ...

Regenxbio's Duchenne gene therapy clears phase 3 hurdle

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks